CJC-1295 w/o DAC + Ipamorelin
Product details
This research blend combines CJC-1295 (a GHRH analog) with Ipamorelin (a selective GHS receptor agonist). The two peptides engage complementary receptor targets on somatotroph cells and are frequently used together in secretagogue signaling research.
Research Applications: - GHRH-R and GHS-R1a co-stimulation kinetics - Pituitary somatotroph signaling studies - Receptor desensitization and tachyphylaxis profiling - Half-life extension via albumin-binding domain analysis - Pulsatile vs. continuous exposure assay design
Blend Composition: - CJC-1295 (no DAC): 2.5mg - 29 amino acid GHRH analog - Ipamorelin: 2.5mg - Selective pentapeptide GHS agonist - Combined Purity: >99% (HPLC verified)
Form: Lyophilized powder Storage: Store at -20°C. Protect from light.